You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
重藥控股(000950.SZ)完成收購重慶醫藥3.35%股權
格隆匯 12-20 21:08

格隆匯12月20日丨重藥控股(000950.SZ)公佈,公司於2019年11月12日、11月28日分別召開第七屆董事會第二十七次會議、2019年第六次臨時股東大會會議,審議通過了《關於收購重慶醫藥(集團)股份有限公司少數股東股權的議案》。

公司已於2019年12月20日在重慶股份轉讓中心辦理完畢公司關於收購重慶醫藥(集團)股份有限公司(以下簡稱“重慶醫藥”)少數股東持有的其3.35%股權過户手續。截止本公告披露日,公司持有重慶醫藥4.4956億股股份,佔重慶醫藥總股比99.94%,重慶化醫控股(集團)公司、深圳茂業(集團)股份有限公司、茂業商業股份有限公司不再持有重慶醫藥股份。涉及公司收購重慶醫藥少數股東股權事宜相關手續已全部履行完畢。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account